StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
The following is a summary of “Association of COMT genetic polymorphism with neuromodulation treatment response in women with ...
Amid rising US tariffs on imports from Canada, China, and Mexico over concerns about fentanyl smuggling, we spoke to experts to explain what fentanyl is and why it is so potent.
Fentanyl is one of the deadliest drugs on the market, particularly for children, who may accidentally ingest it.
New Haven, Connecticut Tuesday, March 11, 2025, 18:00 Hrs [IST] ...
Haduvio met the primary endpoint with a statistically-significant reduction (p<0.0001) in 24-hour cough frequency with a 57% placebo-adjusted c ...
Treatment and recovery services in Spokane County are being enhanced, thanks to funds from an opioid settlement with ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback